|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chesney TR, Metz JJ, Nadler A, Quereshy
FA, Ashamalla S, Acuna SA and Swallow CJ: Long-term outcomes of
resection for locoregional recurrence of colon cancer: A
retrospective descriptive cohort study. Eur J Surg Oncol.
47:2390–2397. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haber PK, Puigvehí M, Castet F, Lourdusamy
V, Montal R, Tabrizian P, Buckstein M, Kim E, Villanueva A,
Schwartz M and Llovet JM: Evidence-based management of
Hepatocellular Carcinoma: Systematic review and meta-analysis of
randomized controlled trials (2002–2020). Gastroenterology.
161:879–898. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thosani N, Guha S and Singh H: Colonoscopy
and colorectal cancer incidence and mortality. Gastroenterol Clin
North Am. 42:619–637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nasseri Y and Langenfeld SJ: Imaging for
colorectal cancer. Surg Clin North Am. 97:503–513. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simon K: Colorectal cancer development and
advances in screening. Clin Interv Aging. 11:967–976. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hon KW, Abu N, Ab Mutalib NS and Jamal R:
miRNAs and lncRNAs as predictive biomarkers of response to FOLFOX
therapy in colorectal cancer. Front Pharmacol. 9:8462018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang K and Karin M: Tumor-elicited
inflammation and colorectal cancer. Adv Cancer Res. 128:173–196.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Candido J and Hagemann T: Cancer-related
inflammation. J Clin Immunol. 33 (Suppl 1):S79–S84. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong H, Jiang L, Lin Y, He C, Zhu G, Du Q,
Wang X, She F and Chen Y: TNF-alpha promotes lymphangiogenesis and
lymphatic metastasis of gallbladder cancer through the
ERK1/2/AP-1/VEGF-D pathway. BMC Cancer. 16:2402016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao Z, Liu Q, Mao F, Wu J and Lei T:
TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic
transformation in pituitary adenomas. Int J Mol Sci. 12:4165–4179.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tanaka T, Imamura T, Yoneda M, Irie A, Ogi
H, Nagata M, Yoshida R, Fukuma D, Kawahara K, Shinohara M and
Nakayama H: Enhancement of active MMP release and invasive activity
of lymph node metastatic tongue cancer cells by elevated signaling
via the TNF-α-TNFR1-NF-κB pathway and a possible involvement of
angiopoietin-like 4 in lung metastasis. Int J Oncol. 49:1377–1384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thanos S and Vanselow J: The effect of
central and peripheral neuroglia on the regeneration of the optic
nerve. Fortschr Ophthalmol. 86:172–175. 1989.(In German).
PubMed/NCBI
|
|
15
|
Olsen RS, Nijm J, Andersson RE, Dimberg J
and Wagsater D: Circulating inflammatory factors associated with
worse long-term prognosis in colorectal cancer. World J
Gastroenterol. 23:6212–6219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mikami S, Mizuno R, Kosaka T, Saya H, Oya
M and Okada Y: Expression of TNF-α and CD44 is implicated in poor
prognosis, cancer cell invasion, metastasis and resistance to the
sunitinib treatment in clear cell renal cell carcinomas. Int J
Cancer. 136:1504–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sang C, Zhang J, Zhang Y, Chen F, Cao X
and Guo L: TNF-α promotes osteoclastogenesis through JNK
signaling-dependent induction of Semaphorin3D expression in
estrogen-deficiency induced osteoporosis. J Cell Physiol.
232:3396–3408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aye IL, Jansson T and Powell TL: TNF-α
stimulates System A amino acid transport in primary human
trophoblast cells mediated by p38 MAPK signaling. Physiol Rep.
3:e125942015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanchavanakit N, Saengtong W,
Manokawinchoke J and Pavasant P: TNF-α stimulates MMP-3 production
via PGE2 signalling through the NF-kB and p38 MAPK pathway in a
murine cementoblast cell line. Arch Oral Biol. 60:1066–1074. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sedger LM and McDermott MF: TNF and
TNF-receptors: From mediators of cell death and inflammation to
therapeutic giants-past, present and future. Cytokine Growth Factor
Rev. 25:453–472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang
JF, Gu Y, Xu F, Xie YY, Zhao XY and Xu RZ: Tetrandrine citrate
eliminates imatinib-resistant chronic myeloid leukemia cells in
vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang
Univ Sci B. 13:867–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lyu L, Hu Y, Yin S, Wang L, Ye F, Wang M,
Zhou Y, Ma W, Chen C, Jiang Y, et al: Autophagy inhibition enhances
anti-pituitary adenoma effect of tetrandrine. Phytother Res.
35:4007–4021. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Yao Z, Lai X, Bao H, Li Y, Li S,
Chang L and Zhang G: Tetrandrine sensitizes nasopharyngeal
carcinoma cells to irradiation by inducing autophagy and inhibiting
MEK/ERK pathway. Cancer Med. 9:7268–7278. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho HS, Chang SH, Chung YS, Shin JY, Park
SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, et al:
Synergistic effect of ERK inhibition on tetrandrine-induced
apoptosis in A549 human lung carcinoma cells. J Vet Sci. 10:23–28.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye LY, Hu S, Xu HE, Xu RR, Kong H, Zeng
XN, Xie WP and Wang H: The effect of tetrandrine combined with
cisplatin on proliferation and apoptosis of A549/DDP cells and A549
cells. Cancer Cell Int. 17:402017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Tsai YH and Tseng SH: The
potential of tetrandrine as a protective agent for ischemic stroke.
Molecules. 16:8020–8032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie W and Du L: Diabetes is an
inflammatory disease: Evidence from traditional Chinese medicines.
Diabetes Obes Metab. 13:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Idec-Sadkowska I, Andrzejak R,
Antonowicz-Juchniewicz J and Kaczmarek-Wdowiak B: Trials of casual
treatment of silicosis. Med Pr. 57:271–280. 2006.(In Polish).
PubMed/NCBI
|
|
29
|
Wang B, Yang L, Yan HL, Wang M and Xiao
JG: Effect of tetrandrine on calcium-dependent tumour necrosis
factor-alpha production in glia-neurone mixed cultures. Basic Clin
Pharmacol Toxicol. 97:244–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferrante A, Seow WK, Rowan-Kelly B and
Thong YH: Tetrandrine, a plant alkaloid, inhibits the production of
tumour necrosis factor-alpha (cachectin) hy human monocytes. Clin
Exp Immunol. 80:232–235. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lunjani N, Tan G, Dreher A, Sokolowska M,
Groeger D, Warwyzniak M, Altunbulakli C, Westermann P, Basera W,
Hobane L, et al: Environment-dependent alterations of immune
mediators in urban and rural south African children with atopic
dermatitis. Allergy. 77:569–581. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wierdak M, Surmiak M, Milian-Ciesielska K,
Rubinkiewicz M, Rzepa A, Wysocki M, Major P, Kłęk S and Pędziwiatr
M: Immunonutrition changes inflammatory response in colorectal
cancer: Results from a pilot randomized clinical trial. Cancers
(Basel). 13:14442021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weitzenfeld P, Kossover O, Körner C,
Meshel T, Wiemann S, Seliktar D, Legler DF and Ben-Baruch A:
Chemokine axes in breast cancer: Factors of the tumor
microenvironment reshape the CCR7-driven metastatic spread of
luminal-A breast tumors. J Leukoc Biol. 99:1009–1025. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen G, Tang N, Wang C, Xiao L, Yu M, Zhao
L, Cai H, Han L, Xie C and Zhang Y: TNF-α-inducing protein of
Helicobacter pylori induces epithelial-mesenchymal transition (EMT)
in gastric cancer cells through activation of IL-6/STAT3 signaling
pathway. Biochem Biophys Res Commun. 484:311–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qiao Y, He H, Jonsson P, Sinha I, Zhao C
and Dahlman-Wright K: AP-1 is a key regulator of proinflammatory
cytokine TNFα-mediated Triple-negative breast cancer progression. J
Biol Chem. 291:5068–5079. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Strekalova E, Malin D, Good DM and Cryns
VL: Methionine deprivation induces a targetable vulnerability in
triple-negative breast cancer cells by enhancing TRAIL receptor-2
expression. Clin Cancer Res. 21:2780–2791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lebrec H, Ponce R, Preston BD, Iles J,
Born TL and Hooper M: Tumor necrosis factor, tumor necrosis factor
inhibition, and cancer risk. Curr Med Res Opin. 31:557–574. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stamova S, Ott-Rötzer B, Smetak H,
Schäffler K, Eder R, Fink I, Hoffmann P, Reichert TE, Beckhove P
and Spanier G: Characterization and ex vivo expansion of rare in
situ cytokine secreting T cell populations from tumor tissue and
blood of oral squamous cell carcinoma patients. J Immunol Methods.
496:1130862021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pilling AB, Hwang O, Boudreault A, Laurent
A and Hwang C: IAP Antagonists enhance apoptotic response to
enzalutamide in castration-resistant prostate cancer cells via
autocrine TNF-α Signaling. Prostate. 77:866–877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee J, Tian Y, Chan ST, Kim JY, Cho C and
Ou JH: TNF-α induced by hepatitis C Virus via TLR7 and TLR8 in
hepatocytes supports interferon signaling via an autocrine
mechanism. PLoS Pathog. 11:e10049372015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li P, Zou J, Dong Y, Jiang J, Liang W and
Li D: Tetrandrine, a potent antifungal agent: Inhibits mycelial
growth and virulence of Botrytis cinerea. Phytopathology.
111:1152–1157. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Serag El-Dien MM, Abdou AG, Asaad NY, Abd
El-Wahed MM and Kora MAEM: Intratumoral FOXP3+ regulatory T cells
in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol.
25:534–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu JY, Feng CP, Li X, Chang MC, Meng JL
and Xu LJ: Immunomodulatory and antioxidative activity of Cordyceps
militaris polysaccharides in mice. Int J Biol Macromol. 86:594–598.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao H, Kong L, Shen J, Ma Y, Wu Z, Li H
and He Y: Tetrandrine inhibits the occurrence and development of
frozen shoulder by inhibiting inflammation, angiogenesis, and
fibrosis. Biomed Pharmacother. 140:1117002021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Eapen MS, Hansbro PM, Larsson-Callerfelt
AK, Jolly MK, Myers S, Sharma P, Jones B, Rahman MA, Markos J, Chia
C, et al: Chronic obstructive pulmonary disease and lung cancer:
Underlying pathophysiology and new therapeutic modalities. Drugs.
78:1717–1740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dai P, Li J, Ma XP, Huang J, Meng JJ and
Gong P: Efficacy and safety of COX-2 inhibitors for advanced
non-small-cell lung cancer with chemotherapy: A meta-analysis. Onco
Targets Ther. 11:721–730. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Minciullo PL, Catalano A, Mandraffino G,
Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S
and Basile G: Inflammaging and anti-inflammaging: The role of
cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz).
64:111–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Feng L, Qi Q, Wang P, Chen H, Chen Z, Meng
Z and Liu L: Serum levels of IL-6, IL-8, and IL-10 are indicators
of prognosis in pancreatic cancer. J Int Med Res. 46:5228–5236.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Manohar M, Kandikattu HK, Verma AK and
Mishra A: IL-15 regulates fibrosis and inflammation in a mouse
model of chronic pancreatitis. Am J Physiol Gastrointest Liver
Physiol. 315:G954–G965. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee CH, Chang JS, Syu SH, Wong TS, Chan
JY, Tang YC, Yang ZP, Yang WC, Chen CT, Lu SC, et al: IL-1β
promotes malignant transformation and tumor aggressiveness in oral
cancer. J Cell Physiol. 230:875–884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cabrero-de Las Heras S and
Martinez-Balibrea E: CXC family of chemokines as prognostic or
predictive biomarkers and possible drug targets in colorectal
cancer. World J Gastroenterol. 24:4738–4749. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Itatani Y, Kawada K, Inamoto S, Yamamoto
T, Ogawa R, Taketo MM and Sakai Y: The role of chemokines in
promoting colorectal cancer invasion/metastasis. Int J Mol Sci.
17:6432016. View Article : Google Scholar : PubMed/NCBI
|
